Antimicrobial resistance patterns of bacteria isolated from milk samples of mastitic goats in Waghimra Zone, Amhara, Ethiopia Authors: Abebe Tibebu, Teklu Yitbarek, Adane Bahiru, Yechale Teshome Published: 2026 ABSTRACT Highlights•Goat-level mastitis prevalence was 24.69%, with SCM (22.28%) predominating over CM (2.52%).•Staphylococcus spp. were the dominant isolates (36.43%), followed by E. coli (9.30%) and Klebsiella spp. (3.34%).•Staphylococcus spp. showed complete ampicillin resistance but high susceptibility to kanamycin and gentamicin.•MDR occurred in 14.89% of isolates and was exclusively detected among Staphylococcus spp. Introduction Goats provide critical sociocultural, economic, and climate-resilience benefits for rural and low-income farmers by generating income and asset accumulation as well as insurance against natural disasters and economic uncertainties. Their low management requirements, tolerance to harsh environments, and increasing demand for their milk and milk products make goats the most prioritized means of livelihood for the landless and women in Asia and Africa (Rouatbi et al., 2022). Despite Ethiopia's goat population surpassing 52 million in 2021, the economic contribution of their milk and milk products remains below its potential (Jemberu et al., 2022). Diseases are among the biggest challenges to animal productivity in Ethiopia and East Africa (Armson et al., 2021), with mastitis being the major constraint to dairy production. Mastitis is an inflammation of the mammary gland primarily caused by bacterial infections (Scaccabarozzi et al., 2015; Vargova et al., 2023). Intramammary infection (IMI) occurs when microorganisms invade and colonize the mammary gland and its secretory tissues, triggering an inflammatory response (Tibebu et al., 2025). Mastitis may also be indirectly influenced by noninfectious factors, including physical or chemical irritants, udder trauma, and poor bedding and milking hygiene, all of which increase exposure to mastitis-causing microorganisms (Zigo et al., 2020). Mastitis is broadly classified into clinical (CM) and subclinical (SCM) forms. Clinical mastitis is the most severe but is less frequent (<7.5%) than SCM (<31.6%) in goats, according to a recent global meta-analysis report (Tibebu et al., 2026a). Mastitis can compromise milk quality by contaminating milk with zoonotic microorganisms, toxins, and antimicrobial residues, thereby increasing the risk of foodborne illness and allergic reactions (Tibebu et al., 2025, 2026a). Staphylococcus, a Gram-positive coccus, is the bacterial genus most frequently associated with mastitis in goats. According to a recent taxonomic revision, mastitis-associated staphylococci are classified as Staphylococcus aureus and non-aureus staphylococci and mammaliicocci (NASM) species (Crippa et al., 2024). Staphylococcus aureus is the most frequently associated bacterial species with CM in goats, followed by E. coli, Streptococcus uberis, and Streptococcus dysgalactiae. In contrast, non-aureus staphylococci and mammaliicocci species are the predominant bacteria associated with SCM, followed by S. aureus and Corynebacterium bovis (Crippa et al., 2024; IDF, 2022; Tibebu et al., 2026a). Because bacteria are the primary cause of mastitis, antimicrobials have long been widely used for its treatment and prophylaxis (Gemeda et al., 2021). Recent mastitis prevention and control recommendations in developed countries targeted antimicrobial use for selective dry period therapy and treatment based on confirmed or highly suspected intramammary infections (Ducháček et al., 2025; Navaei et al., 2025). However, the widespread and indiscriminate use of antimicrobials in developing countries continues to drive the emergence and spread of AMR. Antimicrobial resistance compromises treatment efficacy and the increasing emergence of resistant bacteria poses a significant and growing global public health threat (World Health Organization, 2017). In Ethiopia, small ruminants are predominantly raised under extensive production systems, where farmers often have limited awareness of appropriate antimicrobial use, withdrawal periods, and drug resistance, all of which contribute to their indiscriminate use (Gemeda et al., 2021; Tadesse et al., 2025). Previous studies in Ethiopia have identified Staphylococcus spp. and E. coli as the predominant mastitis-associated bacteria, with substantial AMR prevalences (Amenu et al., 2019; Badaso et al., 2019; Mustefa et al., 2023). However, despite the Amhara region having the third largest goat population in the country, no published research has addressed goat mastitis in this region, with prior investigations largely restricted to central and eastern Ethiopia. This gap is particularly pronounced in Waghimra, an agroecologically distinct dryland zone characterized by smallholder extensive production, where data on the microorganisms associated with goat mastitis and their AMR profiles remain unavailable. To address these gaps, the present study combined California Mastitis Testing (CMT)-based screening, bacteriological isolation, and antimicrobial susceptibility testing with MAR index computation to investigate the major bacterial pathogens associated with mastitis in goats and their AMR patterns. This approach generated the first evidence-based data for this understudied dryland production system, providing a foundation for improved treatment strategies, antimicrobial stewardship, and milk safety. Materials and methods Description of the study areas This study was conducted in the Waghimra Zone of the Amhara Region, Ethiopia, located at 12°23′–13°16′N and 38°44′–39°20′E in the northeastern part of the country. The zone is home to a substantial goat population, most notably the Abergelle breed, which is primarily reared for milk and meat production. Three districts, Ziquala, Sekota, and Abergelle, were purposively selected for their long-standing tradition of goat husbandry and well-established practices in goat milk production and utilization. The total goat population in the study zone exceeds 500,000, with approximately 80–98% of rural households engaged in goat rearing (Tibebu et al., 2026b). The study areas are characterized by lowland and midland agroecologies, dry climatic conditions, and irregular, predominantly unimodal rainfall patterns. The vegetation mainly consists of scattered shrubs and acacia trees (Wondim et al., 2022). Detailed descriptions of rainfall patterns, temperature, and crop and livestock production systems for each district are available in Tibebu et al. (2026c). The map of the study area (Fig. 1) was depicted using ArcGIS software version 10.8.Fig. 1Geographic location of study districts (Abergelle, Sekota, and Ziquala) in Waghimra Zone, northeastern Ethiopia.Fig 1: dummy alt text Geographic location of study districts (Abergelle, Sekota, and Ziquala) in Waghimra Zone, northeastern Ethiopia. Study population The study population comprised all lactating goats kept by village herders under an extensive management system. Goats are allowed to free-graze on communal grazing lands throughout the year and are supplemented with crop byproducts and homemade food leftovers during the dry season. Study design A cross-sectional study was conducted during November–December 2024 to isolate and identify Staphylococcus spp., E. coli, and Klebsiella spp. from milk samples and to evaluate their AMR profiles. Sample size determination The minimum required sample size for the goatherd’s survey was determined using Arsham’s (2005) recommendation:N=0.25SE2 Assuming a 3% standard error (SE) at a 95% confidence level, the minimum sample size was calculated to be 278 goatherds. Goatherds were then proportionally allocated across districts based on the total goat population, the number of eligible goatherds, and the overall sample size. Eligible participants were goat herders aged over 18 years with more than one year of rearing experience whose farms had at least one lactating doe. Accordingly, 118, 88, and 72 goatherds were recruited from Sekota, Abergelle, and Ziquala, respectively. However, three participants from Sekota did not respond and were therefore excluded, resulting in a final sample size of 275 for analysis. The sample size for estimating mastitis prevalence was determined using the formula:N=1.962×Pex×(1−Pex)D2 (Thrusfield & Christley, 2018) Where N = sample size, Pex = expected mastitis prevalence, and D = margin of error. Assuming a 5% margin of error and an expected prevalence of 50% due to the absence of prior studies in the Amhara Region, despite it being one of the largest goat-producing regions in Ethiopia, a minimum sample size of 384 lactating goats was estimated. However, to increase precision, the sample size was adjusted to 397 goats (794 udder halves). The number of goats from each district was proportionally sampled based on female goat population data obtained from the Waghimra Zone Livestock and Fishery Office. Accordingly, 199, 103, and 95 lactating goats were selected from the Sekota, Abergelle, and Ziquala districts, respectively. Sampling approaches A top-down multistage sampling approach was employed (Tibebu et al., 2026b). First, three districts were purposively selected based on the feasibility of field operations and accessibility. Subsequently, three villages with established goat-rearing practices in each district were selected using a random sampling approach. The selected participants were informed about the study objectives and scheduled to participate in a mastitis-screening field day. During the field visit, lactating goats were selected using simple random sampling for mastitis screening. Sample collection and mastitis screening A field mastitis examination schedule was set for late November and December 2024, corresponding to the peak-kidding season for Abergelle goats (personal observation). Clinical mastitis in lactating goats was assessed through systematic observation of the udder and teats for visible abnormalities, including abscesses, hardness, pain, heat, cracks, dryness, asymmetry, color changes, blindness, and functional loss, as described in detail previously by Tibebu et al. (2026b). The stripped milk was also examined for abnormalities such as changes in viscosity, the presence of clots, pus, blood, and other textural alterations. Clinical mastitis was defined as the presence of udder inflammation accompanied by one or more of the clinical signs described above, together with abnormal milk secretion, in accordance with Balemi et al. (2021). Prior to sampling, the udder and teats were thoroughly cleaned with 70% ethyl alcohol and allowed to air dry. The first 3–4 streams of milk were discarded to reduce the number of contaminating bacteria in the teat canal, after which approximately 5 mL of milk was aseptically collected from each affected udder half (equivalent to quarter half in cow) into sterile screw-capped glass bottles. A CMT score of ≥1 was used to define subclinical mastitis, based on the interpretation criteria established by Makau (2017) and Balemi et al. (2021). All collected samples were transported on ice in a cooler box to the Sekota Dryland Agricultural Research Center (SDARC) microbiology laboratory within 12 h. Bacterial isolation and identification Bacterial isolation and identification were performed following standard microbiological guidelines and protocols (Quinn et al., 2011). Besides, media and broth preparation were also performed according to the manufacturer’s guidelines. As the study encompassed multiple locations, the collected samples were stored at +4°C for no longer than 24 h before laboratory analysis. A loopful of milk (10 µL) was transferred into 5 mL buffered peptone water (Himedia, India) and incubated at 37°C for 24 h to obtain sufficient colonies from stressed and low bacterial loads. Subsequently, the buffered peptone water suspension (10 µL) was plated onto Mannitol Salt Agar (Himedia, India) for selective and differential isolation and identification of Staphylococcus spp. (Moura et al., 2018; Xing et al., 2016). Gram staining was performed, and Gram-positive cocci were subjected to biochemical tests including catalase, urease, oxidase, methyl red, and citrate tests for further differentiation. Staphylococcus isolates were identified as Gram-positive cocci arranged in clusters, capable of fermenting mannitol and producing golden-yellow colonies on MSA. Presumptive Staphylococcus isolates showed positive reactions in the catalase, citrate, methyl red, Voges-Proskauer (using MR-VP broth), and urease tests but were negative in the oxidase test performed using the filter-paper method. In parallel, buffered peptone water, suspensions were streaked onto MacConkey agar (Himedia, India) for selective isolation and differentiation of Gram-negative bacteria. Gram staining and microscopy were followed by additional biochemical assays including the triple sugar iron (TSI) test, citrate test, motility test, indole test, MR-VP test, urease test, and catalase tests to identify Gram-negative isolates (Afunwa et al., 2020; Makau, 2017). A Gram-negative, short, rod-shaped bacterium that produced pink lactose-fermenting colonies on MacConkey agar and was further confirmed as negative to urease, oxidase, and Voges-Proskauer (VP) tests, along with being positive to catalase, methyl red (MR), indole, and motility tests, was identified as E. coli. In addition, Klebsiella isolates were identified as Gram-negative, short rod-shaped bacteria producing large, mucoid, lactose-fermenting colonies on MacConkey agar and positive for catalase, citrate, Voges–Proskauer (VP), and urease reactions, but negative for methyl red (MR), indole, and motility tests. To ensure the purity of the presumptive isolates, all colonies from selective media were subcultured onto nutrient agar (Himedia, India) and incubated at 37°C for 24 h. Working stocks were then maintained on nutrient agar slants at 4°C for future laboratory use. Antimicrobial sensitivity testing The antimicrobial susceptibility of bacterial isolates was determined using the Kibry-Bauer disc diffusion test method in accordance with established protocols (CLSI, 2021). From each isolate, three to five colonies grown on nutrient agar were suspended in 5 mL of sterile normal physiological saline and vortexed to achieve a turbidity equivalent to a 0.5 McFarland standard. Approximately 10 µL of bacterial suspensions were uniformly swapped onto the surface of Mueller Hinton agar (Himedia, India) at depth of 4 mm using a sterile wooden-cotton swab. The second and third strokes were made at 90° and 45° angles, respectively, to ensure a uniform distribution of the inoculum. Six antimicrobials from four antimicrobial classes were tested: aminopenicillin (ampicillin, 10µg); aminoglycosides (kanamycin, 30µg; gentamicin, 10µg; streptomycin, 10µg); tetracycline (tetracycline, 30µg), and amphenicols (chloramphenicol, 30µg). The antimicrobials were selected based on either their use in the treatment of infectious diseases in the study area (tetracycline, and streptomycin) or the report in other studies (Balemi et al., 2021). A total of 52 bacterial isolates representing different genera/species were evaluated for AMR using selected commercially available antimicrobial-impregnated discs. The discs were placed on the surface of Mueller–Hinton agar plates, gently pressed with sterile forceps, and incubated at 37°C for 18–24 h. The inhibition zone diameters were measured in millimeters using caliper, and susceptibility categories (resistant, intermediate, or susceptible) were assigned based on CLSI interpretive breakpoints (CLSI, 2021). Statistical analysis All collected data were entered and cleaned in Microsoft Excel, and descriptive summaries, such as frequencies and proportions for mastitis and AMR resistance were performed using STATA version 17 (StataCorp, USA) and WHONET 2025 software. In the WHONET AMR interpretation system, the guideline year was set to 2021, the guideline source was restricted to CLSI, the breakpoint type was limited to animal isolates, and the site of infection was specified as mastitis. The test microorganisms were restricted to the genus level (Staphylococcus and Klebsiella) or the species level (E. coli), and the test method was restricted to the disk diffusion method. Multidrug resistance (MDR) was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories (Magiorakos et al., 2012). The multiple antimicrobial resistance index (MARI) for each isolate was calculated as:MARindex=ab Where, a is the number of antimicrobials to which the isolate was resistant and b is the total number of antimicrobials tested. Bacteria with a MAR index ≥ 0.2 are considered more likely to originate from risk environments (Jain et al., 2021; Sandhu et al., 2016). Result Occurrence of mastitis and bacteria isolated from milk samples Physical examination identified CM in 10 of 397 goats (2.52%) and blind teats in 6 of 397 goats (1.51%). Of the 397 goats examined, two goats, one with bilateral CM and one with bilateral blind teats were excluded from SCM screening, since none of their udder halves remained clinically healthy for CMT testing. This exclusion reduced the denominator for SCM screening from 397 to 395 goats. Among the 395 goats screened, the CMT detected SCM in 88 goats (88/395; 22.28%), comprising 58 unilateral cases (58/395; 14.68%), in which only one udder half was affected while the other had already been identified as CM-positive or healthy, and 30 bilateral cases (30/395; 7.59%), in which both udder halves were subclinically affected. Overall, goat-level mastitis prevalence combining CM and SCM cases was calculated based on the original cohort of 397 goats, yielding a prevalence of 24.69% (98/397). Milk samples processed for bacteriological identification and AMR profiling comprised 11 samples from CM-affected udder halves, including nine samples from goats with unilateral CM and two samples from one goat with bilateral CM, 58 samples from goats with unilateral SCM (one sample per goat), and 60 samples from goats with bilateral SCM (two samples from each of 30 goats), yielding a total of 129 milk samples. Of these, 48.06% (62/129) yielded culture-positive results on selective media. Staphylococcus spp. was the most frequently identified bacteria (36.43%), followed by E. coli (9.30%) and Klebsiella spp. (2.33%). By mastitis type, Staphylococcus spp. was detected in 45.45% of CM cases and 35.59% of SCM cases, while E. coli was identified in 27.27% of CM cases and 7.63% of SCM cases (Table 1).Table 1Bacterial isolates recovered from 129 mastitis milk samples.Table 1 dummy alt textIdentified bacteriaCM (N = 11)SCM (N = 118)Total (N = 129)Staphylococcus5 (45.45%)42 (35.59%)47 (36.43%)E. coli3 (27.27%)9 (7.63%)12 (9.30%)Klebsiella0 (0.00%)3 (2.54%)3 (2.33%)N = number of milk samples; CM = clinical mastitis; SCM = subclinical mastitis. Table 1Bacterial isolates recovered from 129 mastitis milk samples.Table 1 dummy alt textIdentified bacteriaCM (N = 11)SCM (N = 118)Total (N = 129)Staphylococcus5 (45.45%)42 (35.59%)47 (36.43%)E. coli3 (27.27%)9 (7.63%)12 (9.30%)Klebsiella0 (0.00%)3 (2.54%)3 (2.33%)N = number of milk samples; CM = clinical mastitis; SCM = subclinical mastitis. Bacterial isolates recovered from 129 mastitis milk samples. N = number of milk samples; CM = clinical mastitis; SCM = subclinical mastitis. Antimicrobial resistance Antimicrobial susceptibility testing was performed on 37 of the 47 Staphylococcus isolates, along with 12 E. coli and 3 Klebsiella isolates. All Staphylococcus isolates (100%) were resistant to ampicillin but remained highly susceptible to kanamycin (97.30%), gentamicin (94.59%), and chloramphenicol (94.59%). Resistance to tetracycline was detected in 43.24% (16/37) of isolates and to streptomycin in 13.51% (5/37). Among E. coli isolates, resistance to ampicillin was most common (11/12; 91.67%), while resistance to gentamicin, kanamycin, and chloramphenicol was each detected in a single isolate (1/12; 8.33%). All E. coli isolates were susceptible to tetracycline and streptomycin (12/12; 100% each). All Klebsiella isolates were resistant to ampicillin (3/3; 100%), and one isolate (1/3; 33.33%) showed intermediate resistance to tetracycline, while all isolates were susceptible to kanamycin, streptomycin, gentamicin, and chloramphenicol (3/3; 100% each) (Table 2).Table 2Antimicrobial resistance of Staphylococcus, E. coli & Klebsiella isolates.Table 2 dummy alt textBacterial isolatesAntimicrobialsResistant (%)Intermediate (%)Susceptible (%)StaphylococcusAmpicillin37 (100.0)0 (0.0)0(0.0)Chloramphenicol0 (0.0)2 (5.41)35 (94.59)Gentamicin1 (2.70)1 (2.70)35 (94.59)Kanamycin0 (0.0)1 (2.70)36 (97.30)Streptomycin5 (13.51)2 (5.41)30 (81.08)Tetracycline16 (43.24)16 (43.24)5 (13.51)E. coliAmpicillin11(91.67)0 (0.0)1 (8.33)Chloramphenicol1 (8.33)0 (0.0)11(91.67)Kanamycin1 (8.33)0 (0.0)11(91.67)Streptomycin0 (0.0)0 (0.0)12 (100)Tetracycline0 (0.0)0 (0.0)12 (100)Gentamicin1 (8.33)0 (0.0)11(91.67)KlebsiellaAmpicillin3 (100)0 (0.0)0 (0.0)Chloramphenicol0 (0.0)0 (0.0)3 (100)Kanamycin0 (0.0)0 (0.0)3 (100)Streptomycin0 (0.0)0 (0.0)3 (100)Tetracycline0 (0.0)1 (33.33)2 (66.67)Gentamicin0 (0.0)0 (0.0)3 (100) Table 2Antimicrobial resistance of Staphylococcus, E. coli & Klebsiella isolates.Table 2 dummy alt textBacterial isolatesAntimicrobialsResistant (%)Intermediate (%)Susceptible (%)StaphylococcusAmpicillin37 (100.0)0 (0.0)0(0.0)Chloramphenicol0 (0.0)2 (5.41)35 (94.59)Gentamicin1 (2.70)1 (2.70)35 (94.59)Kanamycin0 (0.0)1 (2.70)36 (97.30)Streptomycin5 (13.51)2 (5.41)30 (81.08)Tetracycline16 (43.24)16 (43.24)5 (13.51)E. coliAmpicillin11(91.67)0 (0.0)1 (8.33)Chloramphenicol1 (8.33)0 (0.0)11(91.67)Kanamycin1 (8.33)0 (0.0)11(91.67)Streptomycin0 (0.0)0 (0.0)12 (100)Tetracycline0 (0.0)0 (0.0)12 (100)Gentamicin1 (8.33)0 (0.0)11(91.67)KlebsiellaAmpicillin3 (100)0 (0.0)0 (0.0)Chloramphenicol0 (0.0)0 (0.0)3 (100)Kanamycin0 (0.0)0 (0.0)3 (100)Streptomycin0 (0.0)0 (0.0)3 (100)Tetracycline0 (0.0)1 (33.33)2 (66.67)Gentamicin0 (0.0)0 (0.0)3 (100) Antimicrobial resistance of Staphylococcus, E. coli & Klebsiella isolates. Table 3 presents the multidrug resistance patterns observed. Eight distinct resistance patterns were identified among Staphylococcus and E. coli isolates, with 20 of 49 (40.82%) exhibiting resistance to at least two antimicrobial classes. Among Staphylococcus isolates, 7 of the 37 tested (18.92). The most common MDR pattern involved resistance to ampicillin, streptomycin, and tetracycline, while no MDR isolates were detected among E. coli or Klebsiella. Therefore, the overall MDR pattern was 13.46% (7/52). The overall mean MAR index across all isolates was 0.20, while species-specific MAR index values were 0.23, 0.14, and 0.01 for Staphylococcus, E. coli and Klebsiella, respectively.Table 3MDR patterns among Staphylococcus spp. and E. coli isolates from goat milk.Table 3 dummy alt textBacteriaAMR classAMR PatternResistant Isolates (%)Staphylococcus (N = 37)Aminopen + TetAmp +Tet9 (24.32)Aminopen +AminoAmp +Gen1 (2.70)Aminopen +Amino+TetAmp +Strep + Tet5 (13.51)Aminopen +Amino+TetAmp +Gen+Tet1(2.70)Aminopen+aminoAmp +Gen + Strep1(2.70)Aminopen+Amino+TetAmpc+Gen+Strep+Tet1(2.70)E. coli (N = 12)Aminopen +PhenAmp + Chlor1(8.33)Aminopen+AminoAmp + Gen + Kan1(8.33)Total820 (40.82)N = number of isolates tested; Aminopen = aminopenicillin; Amino = aminoglycosides; Tet = tetracycline; Phen = phenicols; Amp = ampicillin; Strep = streptomycin; Gen = gentamicin; Kan = kanamycin; Chlor = chloramphenicol. Table 3MDR patterns among Staphylococcus spp. and E. coli isolates from goat milk.Table 3 dummy alt textBacteriaAMR classAMR PatternResistant Isolates (%)Staphylococcus (N = 37)Aminopen + TetAmp +Tet9 (24.32)Aminopen +AminoAmp +Gen1 (2.70)Aminopen +Amino+TetAmp +Strep + Tet5 (13.51)Aminopen +Amino+TetAmp +Gen+Tet1(2.70)Aminopen+aminoAmp +Gen + Strep1(2.70)Aminopen+Amino+TetAmpc+Gen+Strep+Tet1(2.70)E. coli (N = 12)Aminopen +PhenAmp + Chlor1(8.33)Aminopen+AminoAmp + Gen + Kan1(8.33)Total820 (40.82)N = number of isolates tested; Aminopen = aminopenicillin; Amino = aminoglycosides; Tet = tetracycline; Phen = phenicols; Amp = ampicillin; Strep = streptomycin; Gen = gentamicin; Kan = kanamycin; Chlor = chloramphenicol. MDR patterns among Staphylococcus spp. and E. coli isolates from goat milk. N = number of isolates tested; Aminopen = aminopenicillin; Amino = aminoglycosides; Tet = tetracycline; Phen = phenicols; Amp = ampicillin; Strep = streptomycin; Gen = gentamicin; Kan = kanamycin; Chlor = chloramphenicol. Discussion The prevalence of mastitis in goats in this study (24.69%), despite being lower than the global threshold (30%), was substantial where raw milk consumption is a tradition. This finding was consistent with the prevalence reported by Badaso et al. (2019) in Ethiopia, but lower than the reports by Balemi et al. (2021) and Mustefa et al. (2023). The lower mastitis prevalence observed in this study may be attributed to differences in study populations, management systems, environmental conditions, diagnostic methods, and pathogen exposure. The study was conducted under smallholder, extensive production systems in a dryland area, where lower stocking density and limited animal contact may reduce pathogen transmission compared with intensive systems. Additionally, the drier environmental conditions in the study area may limit the survival and proliferation of environmental mastitis pathogens in bedding, soil, and water sources, which typically thrive in moist, organically rich environments. This contrasts with intensive or peri-urban dairy systems, where higher stocking densities, shared milking equipment, and more frequent human–animal contact increase opportunities for both contagious and environmental pathogen transmission Bacterial culture is considered the gold standard diagnosis for mastitis; however, culturing all samples may not always be feasible because of resource and financial constraints. Moreover, processing large numbers of samples at a time may increase the risk of analytical errors during handling and laboratory processing. Therefore, only milk samples from CM and SCM cases were subjected to bacteriological investigation in this study. Additionally, identification was also restricted to Staphylococcus, E. coli, and Klebsiella spp. based on their relatively high prevalence in mastitic goat milk and their frequent documentation in Ethiopia and elsewhere (Tibebu et al., 2026b). Accordingly, Staphylococcus was the most frequently identified bacterium, consistent with previous studies conducted in Ethiopia (Amenu et al., 2019; Badaso et al., 2019; Hussen et al., 2023; Mustefa et al., 2023), as well as findings reported from Kenya (Kabui et al., 2024), Algeria (Gabli et al., 2019), and Nigeria (Yoksa et al., 2024). The relatively high proportion of Staphylococcus isolates may be attributed to the absence of routine mastitis diagnosis and control measures, limited awareness of SCM, and the extensive, low-input management systems characteristic of the study area. The persistence of undetected infections, combined with the contagious nature of the bacteria, likely contributes to its continued spread within flocks. Furthermore, the observed bilateral mastitis may reflect underlying gaps in hygiene and infection control, particularly given that milking is performed manually and often without handwashing between animals. Since staphylococci are common skin colonizers, they can act as opportunistic pathogens, causing mastitis and skin infections under favorable conditions (Tibebu et al., 2026b, 2026c). Moreover, the high proportion of Staphylococcus isolates carries important public health implications, given the common practice of raw milk consumption and the limited awareness of zoonotic disease transmission in the study area. Escherichia coli was the second most predominant bacterium identified in goats with mastitis, consistent with previous reports from Ethiopia (Amenu et al., 2019; Badaso et al., 2019; Mustefa et al., 2023). Similar findings have also been reported in Botswana (Mugabe et al., 2017), Kenya (Mahlangu et al., 2018), and China (Zhao et al., 2015), where E. coli was likewise the second most frequently isolated bacterium from milk samples of mastitic goats. This consistent ranking across geographically diverse settings suggests that mastitis due to E. coli in small ruminants is driven less by region-specific factors and more by shared husbandry conditions common to extensive production systems. Unlike contagious pathogens such as Staphylococcus spp., which spread primarily through the milking process and animal-to-animal contact, E. coli is a classical environmental pathogen whose presence reflects the degree of contamination in the animal's surroundings, particularly bedding, floor surfaces, and water sources (Mahlangu et al., 2018; Zhao et al., 2015). The relatively high proportion of E. coli observed in this study therefore likely reflects specific lapses in udder and environmental hygiene, such as inadequate pre-milking teat preparation, contaminated bedding, and limited disinfection practices. In the study areas, housing is often rudimentary and teat disinfection rarely practiced, leaving the mammary gland persistently exposed to fecal and soil-borne coliforms between milkings and increasing the opportunity for E. coli to ascend the teat canal and establish infection. This contrasts with intensive systems, where structured milking protocols and routine teat disinfection substantially reduce environmental pathogen load. This study also evaluated the susceptibility of the isolated bacteria to commonly used veterinary antimicrobial drugs. To ensure the reliability of these results, maximum precautions were taken to safeguard disc potency and medium quality, including the use of commercially prepared, quality-assured antimicrobial discs stored and handled according to the manufacturer's instructions, as well as freshly prepared Mueller-Hinton agar for each testing batch. Under these standardized conditions, antimicrobial susceptibility testing revealed that Staphylococcus was completely resistant to ampicillin and moderately resistant to tetracycline and streptomycin. This finding is consistent with other reports from Ethiopia; Balemi et al. (2021) reported 100% resistance to penicillin, while Mohammed (2023) reported resistance of 76.9% to ampicillin, 57.7% to tetracycline, and 30.7% to streptomycin. Similarly, resistance to ampicillin and tetracycline has been documented elsewhere, including by Chu et al. (2012) in Taiwan, Mahlangu et al. (2018) in Kenya, and Chandra et al. (2024) in India. In addition, Pratap et al. (2023) reported that S. aureus exhibited resistance to ampicillin (65.15%), gentamicin (36.15%), tetracycline (18.78%), and chloramphenicol (17%). The observed high resistance by Staphylococcus to ampicillin and tetracycline may be due to the long-term dependence of these antimicrobials against lots of infectious diseases. Some staphylococcal strains exhibit acquired resistance to penicillin drugs through resistance genes (Datanasio et al., 2015; Tkhilaishvili et al., 2018). Farmers in the lowlands of Ethiopia, including the study area, frequently administer antimicrobials (mostly tetracycline and penicillin-streptomycin (Pen-Strep)) without veterinary consultation and have limited awareness of appropriate use, dosage, withdrawal periods, and potential side effects, which may contribute to the observed high antimicrobial resistance in Staphylococcus (Gemeda et al., 2020). Moreover, a meta-analysis estimated high penicillin resistance occurrence of S. aureus from bovine mastitis in Asia, and Africa (Molineri et al., 2021). Staphylococcus isolates showed high susceptibility to kanamycin, chloramphenicol, and gentamicin, consistent with the findings of Mohammed (2023), who reported the high susceptibility of Staphylococcus to kanamycin and gentamicin. However, this contrasts with studies by Balemi et al. (2021), Mbindyo et al. (2014), and Rychshanova et al. (2022), who reported high resistance to kanamycin and chloramphenicol. The high susceptibility of Staphylococcus spp. to these antimicrobials may be attributed to their limited use in veterinary practice in Ethiopia, resulting in minimal selective pressure. E. coli isolates in the present study were found with a high level of resistance to ampicillin and, to a lesser extent, gentamicin and chloramphenicol. This finding is consistent with previous AMR reports of E. coli against chloramphenicol (Balemi et al., 2021; Mbindyo et al., 2014), on tetracycline (Mahlangu et al., 2018), and on kanamycin (Mbindyo et al., 2014). Gemeda et al. (2021) reviewed that several bacteria from milk samples developed resistance to tetracycline, streptomycin, kanamycin, chloramphenicol, gentamicin and ampicillin. Klebsiella showed 100% resistance to ampicillin, which was expected because Klebsiella species are intrinsically resistant to ampicillin and other aminopenicillins. MDR was detected in 18.92% of tested Staphylococcus spp., whereas no MDR E. coli or Klebsiella isolates were identified. Similar findings of significant MDR proportions among Staphylococcus have been reported, including 100% MDR in Ethiopia, Jordan, and Bangladesh (Balemi et al., 2021; Obaidat et al., 2018; Rana et al., 2020). Moderate levels of MDR among Staphylococcus have also been documented elsewhere, including 56% in China (Liu et al., 2023), 43% in Pakistan (Javed et al., 2024), and 23% in Brazil (Santos et al., 2020). In contrast, Awosile et al. (2018) reported a low MDR prevalence (2.7%) of E. coli in Canada. A meta-analyses report also indicated a very high MDR prevalence for NAS (96%) and S. aureus (58%) (Gemeda et al., 2021). Furthermore, the MARI computed for Staphylococcus was found to be greater than 0.23, indicating a high-risk area of contamination (Afunwa et al., 2020; Jain et al., 2021; Sandhu et al., 2016). MARI is a valuable tool for guiding antimicrobial selection and an early warning for communicating the risk of antimicrobial resistance to livestock owners and other relevant stakeholders. Moreover, the combined assessment of AMR patterns and MARI profiles can help clinicians determine whether current antimicrobial prescribing practices remain appropriate or should be modified in favor of more effective and affordable alternative antimicrobials. The findings of this study provide valuable information for both veterinarians and goat keepers in the field. The observed occurrence of CM and SCM highlights the importance of routine udder health monitoring and use of screening techniques such as the CMT for early detection and intervention. The identification of the major bacterial genera associated with mastitis in goats and their AMR patterns can support evidence-based treatment decisions and promote the prudent use of antimicrobials. Collectively, these measures can contribute to improved animal health, enhanced milk production, reduced economic losses, and mitigation of AMR development in goat production systems. Limitation of the study This study has several limitations. Bacterial identification relied on conventional cultural, morphological, and biochemical methods without molecular confirmation, and Staphylococcus and Klebsiella were identified only to the genus level, with no coagulase test performed to differentiate staphylococcal species. Quality control reference strains were not included during antimicrobial susceptibility testing, although quality-assured commercial discs and freshly prepared media were used to minimize this limitation, and susceptibility testing was not performed on all recovered isolates. Conclusion and recommendations The substantial mastitis burden has important implications for milk production, animal welfare, and public health in the study area, where raw milk consumption is common. Goat mastitis, predominantly subclinical, was prevalent in the study area, with Staphylococcus spp. the leading cause, followed by E. coli and Klebsiella spp. Staphylococcus spp. showed complete resistance to ampicillin and considerable resistance to tetracycline. All MDR patterns were detected in staphylococcus isolates. This substantial mastitis burden carries important implications for milk production, animal welfare, and public health, particularly given the common practice of raw milk consumption in the study area. Future studies employing molecular identification, species characterization, and susceptibility testing are recommended to more comprehensively characterize antimicrobial resistance in mastitis pathogens. Ethics approval and consent to participate The study was approved by Sekota Dryland Agricultural Research Center Animal Health Research Review Committee (SDARC-AHRRC/23/05/2023). All animal sampling procedures comply with the ARRIVE guidelines and in accordance with the U.K. Animals (Scientific Procedures) Act, 1986. Ethics declaration This study was conducted in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. This study was approved by the Sekota Dryland Agricultural Research Center Animal Health Research Review Committee. Funding This work was supported by the Amhara Agricultural Research Institute (S/LRD/AH/14/2023), Ethiopia. CRediT authorship contribution statement Abebe Tibebu: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Teklu Yitbarek: Writing – review & editing, Writing – original draft, Investigation, Data curation. Adane Bahiru: Writing – review & editing, Writing – original draft, Supervision, Methodology, Conceptualization. Yechale Teshome: Writing – review & editing, Writing – original draft, Supervision, Methodology, Conceptualization. Declaration of competing interest The authors declare no competing interests.